The breast cancer patients who are heterozygous and homozygous for decreased function and null alleles of CYP2D6 showed lower plasma concentrations of endoxifen and 4 hydroxytamoxifen compared to patients with homozygous wild type allele, resulting in worse clinical outcome in tamoxifen therapy
how long does stromectol stay in your system